The Company has generated over $27 million in cumulative recreational cannabis sales since legalization on October 17, 2018 , with an average gross margin of over 31%.

Q2-2019 total revenue of $16.2 million represents a 328% increase versus prior quarter total revenue.

23 retail cannabis stores open at the end of Q2-2019.

The Company expects to have 40 stores open and operating by the end of calendar 2019.

TORONTO, April 16, 2019 /CNW/ - National Access Cannabis Corp. ("NAC" or the "Company") (TSXV: META), the largest private retailer of recreational cannabis in Canada, today announced its financial results for the second quarter ended February 28, 2019. All amounts are expressed in Canadian dollars.

"With 23 stores operating in two provinces, seven applications underway in B.C. and a focused strategy for Ontario, we are poised to continue growing our leading footprint at a national level, while driving solid financial performance for our shareholders," said Mark Goliger, CEO of NAC. "I am very proud of our team's operational execution, which has resulted in our retail cannabis operating business unit generating consistently strong revenue growth and positive Adjusted EBITDA. Our team is focused on accretively building our national retail footprint to 40 stores by the end of calendar 2019, while maximizing the same-store sales growth and contribution of individual store locations. As the Canadian cannabis market finds its footing, we also expect supply issues to begin to abate, which will enable us to continue offering our customers the wide selection they are used to, while optimizing our working capital and Adjusted EBITDA for the benefit of shareholders."

This press release should be read in conjunction with the unaudited condensed interim consolidated financial statements and accompanying notes for the three and six months ended February 28, 2019 and the related Interim MD&A – Quarterly Highlights for the three and six-month period ended February 28, 2019.

_______________________________ 1 Adjusted EBITDA is a non-IFRS measure that does not have a standardized meaning prescribed by IFRS. For more information and a reconciliation of non-IFRS measures to the closest IFRS measure, see below under "Financial Measures", or find additional detail in the "Non-IFRS Financial Measures" section in the Company's Interim MD&A – Quarterly Highlights for the three and six-month period ended February 28, 2019, available on SEDAR and on the Company's website.

Select Operating Highlights

The Company currently operates 23 recreational cannabis retail stores, 14 in Alberta and 9 in Manitoba .

and 9 in . Announced the appointment of Michael Cosic as Chief Financial Officer and Lori Bailey as Senior Vice-President of Retail.

as Chief Financial Officer and as Senior Vice-President of Retail. The Company entered into a share purchase agreement with the shareholders of New Leaf Emporium, which will enable NAC to expand into Saskatchewan through an operating Moose Jaw location, and an e-commerce license 2 .

through an operating location, and an e-commerce license . Entered into a six-month $9,000,000 loan agreement with Opaskwayak Cree Nation; carrying an interest rate of 8% per annum.

loan agreement with Opaskwayak Cree Nation; carrying an interest rate of 8% per annum. Acquired all of NAC Alberta Inc.'s minority interest in NAC Northern Alberta GP and NAC Northern Alberta Limited Partnership, giving NAC 100% ownership of various leaseholds, and rights to operate retail locations in Northern Alberta .

Select Financial Highlights – Three Months Ended February 28, 2019



Medical Cannabis

Education Clinics Retail Cannabis

Stores Research Corporate Total Revenue 320,114 15,881,986 - - 16,202,100 Cost of goods sold (47,009) (10,925,275) - - (10,972,284) Gross profit Gross profit margin (%) 273,105 85% 4,956,711 31% -

n/a - n/a 5,229,816 32% Operating expenses (598,928) (4,965,013) (168,302) (4,011,736) (9,743,979) Loss from operations (325,823) (8,301) (168,302) (4,011,736) (4,514,163) Adjusted EBITDA Adjusted EBITDA % (240,178) n/a 1,769,914 11% (168,302) n/a (2,722,554) n/a (1,361,420) n/a Other expenses - - - (1,133,591) (1,133,591) Net loss (325,823) (8,301) (168,302) (5,145,327) (5,647,754)

Select Financial Highlights – Six Months Ended February 28, 2019



Medical Cannabis

Education Clinics Retail Cannabis

Stores Research Corporate Total Revenue 814,994 19,174,333 - - 19,989,328 Cost of goods sold (138,332) (13,173,259) - - (13,311,591) Gross profit Gross profit margin (%) 676,663 83% 6,001,074 31% -

n/a - n/a 6,677,737 33% Operating expenses (1,197,253) (7,324,560) (304,460) (7,981,497) (16,807,770) Loss from operations (520,990) (1,323,486) (304,460) (7,981,497) (10,130,033) Adjusted EBITDA Adjusted EBITDA % (367,235) n/a 2,362,888 12% (304,460) n/a (5,168,986) n/a (3,477,793) n/a Other expenses - - - (3,393,872) (3,393,872) Net loss (520,590) (1,323,486) (304,460) (11,375,369) (13,523,905)

________________________ 2 Subject to the close of the acquisition and regulatory approval.

Financial Measures

There are measures included in this news release that do not have a standardized meaning prescribed by IFRS and therefore may not be comparable to similarly titled measures and metrics presented by other publicly traded companies. The Company includes these measures because it believes certain investors use these measures and metrics as a means of assessing financial performance. EBITDA (earnings before interest, taxes, depreciation and amortization) is a non-IFRS financial measure that does not have any standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other companies.

Adjusted EBITDA

Three months ended February 28,

2019 Medical Cannabis

Education Clinics Retail

Cannabis

Stores Research Corporate Total Loss from operations (325,823) (8,301) (168,302) (4,011,736) (4,514,163) Amortization of property and equipment 86,645 372,311 - - 457,956 Amortization of intangible assets - - - 419,133 419,133 Professional fees – fundraising and

acquisition - - - 283,113 283,113 Integration and restructuring costs - - - 213,472 213,472 Pre-operating retail expenses - 1,405,604 - - 1,405,604 Share based compensation - - - 373,464 373,464 Adjusted EBITDA (240,178) 1,769,914 (168,302) (2,722,554) (1,361,420)

Six months ended February 28, 2019 Medical Cannabis

Education Clinics Retail

Cannabis

Stores Research Corporate Total Loss from operations (520,590) (1,323,486) (304,460) (7,981,497) (10,130,033) Amortization of property and equipment 153,355 428,452 - - 581,807 Amortization of intangible assets - - - 838,266 838,266 Professional fees – fundraising and

acquisition - - - 922,594 922,594 Integration and restructuring costs - - - 380,480 380,480 Pre-operating retail expenses - 3,257,922 - - 3,257,922 Share based compensation - - - 671,171 671,171 Adjusted EBITDA (367,235) 2,362,888 (304,460) (5,168,986) (3,477,793)

Management defines Adjusted EBITDA as the net loss from operations, as reported, before interest, tax, and adjusted by removing non-cash items, including stock-based compensation expense, depreciation, and further adjusted to remove integration and restructuring related costs, as well as upfront costs required to open a retail store. Management believes Adjusted EBITDA is a useful financial metric to assess its operating performance on a cash adjusted basis before the impact of non-cash items and acquisition related costs. Adjusted EBITDA is a non-IFRS financial measure that does not have any standardized meaning and therefore may not be comparable to similar measures presented by other issuers.

NAC Enters into Agreement to Issue Shares for Services

The Company today announced that National Access Canada Corporation ("NACC"), a subsidiary of NAC, has entered into an agreement with Kyle Wilson, pursuant to which NACC has agreed to issue common shares of the Company to Kyle Wilson in exchange for consulting services previously rendered by Kyle Wilson. Pursuant to the terms of the agreement, NACC will pay a total fee of $82,800, to be paid by way of common shares of the Company.

Pursuant to TSX Venture Exchange Policy 4.3 – Shares for Debt, the deemed price of the securities to be issued is $0.92, being the Market Price (as such term is defined in the policies of the TSX Venture Exchange) of the common shares of the Company on the last trading day before the date of the agreement. The issuance of common shares to Kyle Wilson is subject to approval of the TSX Venture Exchange.

NAC Grants Stock Options to Officer of the Company

The Company has granted stock options to purchase an aggregate of 500,000 common shares of the Company to an officer of NAC. The stock options have an exercise price of $0.92 per common share and expire four years from the date of grant. One-fifth of the options granted vest six months following the date of the grant, with the remainder of the options vesting over the course of four installments, each installment vesting every three months thereafter.

About National Access Cannabis Corp.

NAC is Canada's largest recreational cannabis retailer. With 23 retail locations nationwide, NAC is the leader in secure, safe and responsible access to legal recreational cannabis in Canada. Through its Canada-wide network of Meta Cannabis Supply Co.™ and NewLeaf Cannabis™ recreational cannabis retail stores and NAC Medical's cannabis clinics and pharmacy partnerships, NAC enables the public and registered patients to gain knowledgeable access to Canada's network of authorized Licensed Producers of cannabis. NAC is listed on the TSX Venture Exchange under the symbol (TSXV: META).

For more information, visit:

www.nationalaccesscannabis.com

www.metacannabis.com

www.newleafcannabis.ca

www.nacbio.com

www.nacmedical.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements

This news release contains forward looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward looking statements or information. Forward-looking statements and information in this news release includes, but is not limited to, the planned opening of cannabis retail stores and the planned opening dates of same, the number of NAC cannabis retail stores expected to open and/or become licensed, the locations of cannabis retail stores, the launch of an online cannabis retail store in Manitoba, the abatement of supply issues relating to cannabis in Canada, NAC's plan to establish retail cannabis distribution networks in Canada, New Leaf Emporium receiving a cannabis retail permit granted by the Saskatchewan Liquor and Gaming Authority in respect of its premises in Moose Jaw, Saskatchewan, the successful closing of the purchase of New Leaf Emporium and NAC's anticipated expansion into Saskatchewan. Although the Company believes that the expectations and assumptions on which the forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company cannot give any assurance that they will prove to be correct. Since forward looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results and developments may differ materially from those that are currently contemplated by these statements depending on, among other things, risks relating to the ability to obtain or maintain licenses to retail cannabis products; future legislative and regulatory developments involving cannabis; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the labour market generally and the ability to access, hire and retain employees; and the medical and retail cannabis industry in Canada generally. The Company cautions that the foregoing list of risks and uncertainties is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statement or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

SOURCE National Access Cannabis Corp.

For further information: National Access Cannabis: Mark Goliger, Chief Executive Officer, National Access Cannabis, Tel : 647-689-6382, [email protected]; Investor Relations: Emily Gibbs, LodeRock Advisors Inc., Tel: 416-546-8775, [email protected]; Media Inquiries: Jessica Patriquin, Tel : 416-640-5525 x 230, Cell : 416-995-8496, [email protected]

Related Links

www.NationalAccessCannabis.com

